Top Markets
#1 Islamic Coin Islamic Coin +158.15%
#2 Glidr Glidr +58.56%
#3 Cryptopia Cryptopia +19.80%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.49%
#5 Victoria VR Victoria VR +8.64%
#6 DMT-NAT DMT-NAT +6.65%
#7 Pons Pons +6.24%
#8 COTI COTI +6.21%
#9 龙虾 (Lobster) 龙虾 (Lobster) +5.86%
#10 Movement Movement +5.43%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Upper Street Marketing Inc. Upper Street Marketing Inc.

Upper Street Marketing Inc.

UPPR
Rank in Stocks #41894
Upper Street Marketing Inc. engages in the acquisition of distinctive... Upper Street Marketing Inc. engages in the acquisition of distinctive businesses with proven strengths and potential for growth. The company is based in Scottsdale, Arizona.
Share Price
$0.0001
Last synced: 2026-08-11
Market Cap
$8.00K
Change (1 day)
0.00%
Change (1 year)
42.86%
Country
US
Trade Upper Street Marketing Inc. (UPPR)

Category

Healthcare
Revenue for Upper Street Marketing Inc. (UPPR)
Revenue in Aug 2026 TTM: 0
According to Upper Street Marketing Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Upper Street Marketing Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US